黄芪甲苷通过抑制STING通路减轻D-半乳糖诱导的心肌细胞衰老和凋亡
目的探讨黄芪甲苷(AS-Ⅳ)对D-半乳糖(D-gal)诱导的心肌细胞衰老的保护作用及其潜在机制。方法以心肌细胞H9C2为模型,采用D-gal诱导心肌细胞衰老,通过CCK-8法检测细胞活力,β-半乳糖苷酶(SA-β-Gal)染色评估细胞衰老程度,ROS检测细胞内活性氧水平,TUNEL检测细胞凋亡程度,qRT-PCR和Western blot检测衰老相关基因和蛋白(p21、p53)及干扰素基因刺激因子(STING)通路关键基因(STING、CXCL10和 MX-1)和蛋白(STING、cGAS、p-IRF3/
郭文玉 +6 more
doaj
[Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. [PDF]
Liang G +8 more
europepmc +1 more source
[The clinical study of azacitidine and lenalidomide combination in myelodysplastic neoplasm patients with TP53 mutations]. [PDF]
Yan X +8 more
europepmc +1 more source
[Astragaloside IV alleviates D-GAL-induced endothelial cell senescence by promoting mitochondrial autophagy via inhibiting the PINK1/Parkin pathway]. [PDF]
Yi M +6 more
europepmc +1 more source
[Effect and mechanism of astaxanthin on the aging of high glucose-treated human skin fibroblasts]. [PDF]
Tang LJ +6 more
europepmc +1 more source
目的探讨基于免疫组化法的三阴性乳腺癌(TNBC)分子分型,观察不同分子分型患者的临床病理特征及预后差异。方法根据雄激素受体(AR)、分化簇8(CD8)、叉头框蛋白C1(FOXC1)、双皮质素样激酶1(DCLK1)免疫组化表达情况进行分子分型,比较各亚型间临床、病理特征及预后差异。结果110例TNBC中腔面雄激素受体亚型35例(31.8%),免疫调节亚型24例(21.8%),基底样免疫抑制型34例(30.9%),间充质亚型17例(15.5%)。各亚型之间临床病理特征中组织学分级(P<0.001 ...
陈菊华 +5 more
doaj
[Clinical characteristics, treatment, and prognosis of double-hit multiple myeloma with concurrent 1q21+ and t (4;14)]. [PDF]
Guo Y +8 more
europepmc +1 more source
[Role and mechanisms of FoxO3a-related signaling pathways in breast cancer cell apoptosis]. [PDF]
Wang Z +5 more
europepmc +1 more source
[Allogeneic hematopoietic stem cell transplantation for pediatric acute leukemia harboring the <i>PICALM-MLLT10</i> fusion in two cases]. [PDF]
Chen Y +6 more
europepmc +1 more source
[Clinical Progress and Prospects of mRNA Tumor Drugs]. [PDF]
Chen J +5 more
europepmc +1 more source

